A mouse model for creatine transporter deficiency reveals early onset cognitive impairment and neuropathology associated with brain aging

Laura Baroncelli, Angelo Molinaro, Francesco Cacciante, Maria Grazia Alessandrì, Debora Napoli, Elena Putignano, Jonida Tola, Vincenzo Leuzzi, Giovanni Cioni, Tommaso Pizzorusso

Research output: Contribution to journalArticlepeer-review

Abstract

Mutations in the creatine (Cr) transporter (CrT) gene lead to cerebral creatine deficiency syndrome-1 (CCDS1), an X-linked metabolic disorder characterized by cerebral Cr deficiency causing intellectual disability, seizures, movement and autistic-like behavioural disturbances, language and speech impairment. Since no data are available about the neural and molecular underpinnings of this disease, we performed a longitudinal analysis of behavioural and pathological alterations associated with CrT deficiency in a CCDS1 mouse model. We found precocious cognitive and autistic-like defects, mimicking the early key features of human CCDS1. Moreover, mutant mice displayed a progressive impairment of short and long-term declarative memory denoting an early brain aging. Pathological examination showed a prominent loss of GABAergic synapses, marked activation of microglia, reduction of hippocampal neurogenesis and the accumulation of autofluorescent lipofuscin. Our data suggest that brain Cr depletion causes both early intellectual disability and late progressive cognitive decline, and identify novel targets to design intervention strategies aimed at overcoming brain CCDS1 alterations.

Original languageEnglish
Pages (from-to)4186-4200
Number of pages15
JournalHuman Molecular Genetics
Volume25
Issue number19
DOIs
Publication statusPublished - Oct 1 2016

Keywords

  • Journal Article

Fingerprint Dive into the research topics of 'A mouse model for creatine transporter deficiency reveals early onset cognitive impairment and neuropathology associated with brain aging'. Together they form a unique fingerprint.

Cite this